A related systematic review evaluating PD-L1 expression in patients identified as MMR-deficient demonstrated that such PCa cases showed MSI in 11% of cases, out of which 12% were PD-L1-positive [25]. This evidence concerns the gene CD274 and posterior cortical atrophy.